Cryo AF Global Registry

ClinicalTrials.gov Identifier: NCT02752737

Purpose

Cryo AF Global Registry a prospective, global, multi-center, observational Post-Market Registry

Sponsor: Medtronic
Condition: Atrial Fibrillation

Observational: Patient Registry

The Cryo AF Global Registry is a prospective, global, multi-center, observational post-market registry (PMR). The purpose of this study is to evaluate and describe clinical performance and safety data in a broad patient population treated with a commercially available Arctic Front™ Family of Cardiac Cryoablation Catheters (hereafter referred to as “Arctic Front™ Cardiac Cryoablation Catheter System”). The cryoballoon ablation(CBA) procedure will be performed according to routine hospital practice. The study is expected to have a 24 month enrollment period. The follow up period is intended to align with standard practice and subjects will be followed for a minimum of 12 months post-procedure.

More information via clinicaltrials.gov